In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: A Canadian multicentre study

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue SUPPL. A, 1999, Pages 3-23

  Blondeau, Joseph M ^a,c   Yaschuk, Y ^a   Suter, M ^a   Vaughan, David ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b Anti Infective Division   (Canada)

^c ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CARBENICILLIN; CEFAMANDOLE; CEFONICID; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; IMIPENEM; MEZLOCILLIN; NETILMICIN; SULTAMICILLIN; TICARCILLIN; TIMENTIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ENTEROBACTERIACEAE; HUMAN; IN VITRO STUDY; MULTICENTER STUDY; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; CEFOPERAZONE; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACIDS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENTEROCOCCUS; HAEMOPHILUS; HUMANS; IMIPENEM; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; MORAXELLA; PSEUDOMONAS; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCUS; STREPTOCOCCUS; TICARCILLIN; URINARY TRACT INFECTIONS;

EID: 0033012938     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Marrie, T. J. (1993). Pneumonia - a major challenge. Canadian Journal of Infectious Diseases 4, Suppl. A, 5A-9A.
2. Woodhead, M. A., Arrowsmith, J., Chamberlain-Webber, R., Wooding, S. & Williams, I. (1991). The value of routine microbial investigation in community-acquired pneumonia. Respiratory Medicine 85, 313-7.
3. Johnson, J. R. & Stamm, W. E. (1989). Urinary tract infections in women: diagnosis and treatment. Annals of Internal Medicine 111, 906-17.
4. Harding, G. K., Nicolle, L. E., Ronald, A. R., Preiksaitis, J. K., Forward, K. R., Low, D. E. et al. (1991). How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study. Annals of Internal Medicine 114, 713-9.
5. Nicolle, L. E. (1992). Urinary tract infection in the elderly. How to treat and when? Infection 20, Suppl. 4, S261 -5.
6. Louie, T. J. & the Committee on Antimicrobial Agents. Canadian Infectious Disease Society. (1994). Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Canadian Medical Association Journal 150, 669-76.
7. Kunin, C. M. (1993). Resistance to antimicrobial drugs - a worldwide calamity. Annals of Internal Medicine 118, 557-61.
8. Walker, R. C. & Wright, A. J. (1991). The fluoroquinolones. Mayo Clinic Proceedings 66, 1249-59.
9. Wiedemann, B. & Zuhlsdorf, M. T. (1989). Resistance development to fluoroquinolones in Europe. American Journal of Medicine 87, Suppl. 5A, 9S-11S.
10. Doern, G. V. (1995). Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. American Journal of Medicine 99, Suppl. 6B, S3-S7.
11. Blondeau, J. M., Yaschuk, Y. & the Canadian Ciprofloxacin Study Group. (1996). Canadian Ciprofloxacin susceptibility study: comparative study from 15 medical centres. Antimicrobial Agents and Chemotherapy 40, 1729-32.
12. Hoban, D. J., Jones, R. N. & the Canadian Ofloxacin Study Group. (1995). Canadian ofloxacin susceptibility study: a comparative study from 18 medical centres. Chemotherapy 41, 34-8.
13. Coronado, V. G., Edwards, J. R., Culver, D. H., Gaynes, R. P. & the National Nosocomial Infections Surveillance (NNIS) System. (1995). Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. Infection Control and Hospital Epidemiology 16, 71-5.
14. National Committee for Clinical Laboratory Standards. (1994). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A7. NCCLS, Villanova, PA.
15. Blondeau, J. M., Suter, M. & the Canadian Antimicrobial Resistance Group. (1997). Antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis: comparison of 3 test methods. In Proceedings of the Twentieth International Congress of Chemotherapy, Sydney, Australia, 1997. Abstract P001-4204, p. 52. Organizing Committee of the International Congress of Chemotherapy, Victoria, Australia.
16. Blondeau, J. M., Shiplett, M. E. & the Canadian Study Group. (1995). Canadian Pseudomonas aeruginosa susceptibility study: a comparative study from 55 medical centres. In Proceedings of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract E127, p. 108. American Society for Microbiology, Washington, DC.
17. Hoban, D. J., Jones, R. N., Harrell, L. J., Knudson, M. & Sewell, D. (1993). The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistance. Diagnostic Microbiology and Infectious Disease 17, 157-61.
18. Forward, K. R., Franks, P., Low, D. E., Laverdiere, M., Rennie, R., Simor, A. E. et al. (1996). A cross Canada survey of resistance to piperacillin-tazobactam and other antibiotics against 2747 aerobic blood culture isolates. In Proceedings of the Thirty-Sixth Annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract E14, p. 83. American Society for Microbiology, Washington, DC.
19. Simor, A. E., Louie, M., Low, D. E. & the Canadian Bacterial Surveillance Network. (1996). Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 40, 2190-3.
20. Toye, B. W., Scriver, S. R., Low, D. E. & the Canadian Antimicrobial Resistance Study Group. (1993). Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter spp. Journal of Antimicrobial Chemotherapy 32, Suppl. B, 81-6.
21. Chamberland, S. L., L'Ecuyer, J., Lessard, C., Bernier, M., Provencher, P., Bergeron, M. G. et al. (1992). Antibiotic susceptibility profiles of 941 Gram-negative bacteria isolated from septicemic patients throughout Canada. Clinical Infectious Diseases 15, 615-28.
22. Tillotson, G., Culshaw, K. & O'Keeffe, B. (1994). Gram-negative bacterial susceptibility to Ciprofloxacin - a six year UK perspective. In Proceedings of the Sixth International Congress on Infectious Diseases, Prague, 1994. Abstract 136. International Society for Infectious Diseases.
23. Blondeau, J. M., Suter, M. E. & the Canadian Antimicrobial Resistance Study Group. (1999). Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis to several antimicrobial agents. Journal of Antimicrobial Chemotherapy 43, Suppl. A, 25-30.